The Comprehensive Guide to Afatinib 20mg Tablets In the evolving field of precision oncology, Afatinib 20mg Tablets represent a breakthrough in the targeted treatment of non-small cell lung cancer (NSCLC). As a leading pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this specialized tyrosine kinase inhibitor (TKI) is available to healthcare providers and patients in London, New York, Sydney, Johannesburg, and beyond. Product Specifications Brand Name: Ernest-Oncology (Afatinib Dimaleate) Strength: 20mg per tablet Dosage Form: Oral Tablet Primary Indication: Metastatic non-small cell lung cancer (NSCLC) with EGFR mutations. Storage: Store at room temperature (20°C to 25°C), protected from light and moisture. Mechanism of Action: How It Works Inhibiting Multiple Receptors: It works by binding to and permanently inhibiting signaling from EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4). Stopping Tumor Growth: By blocking these receptors, Afatinib shuts down the signaling pathways responsible for the growth and spread of cancer cells, specifically those harboring abnormal epidermal growth factor receptor (EGFR) genes. Therapeutic Indications & Administration First-line Treatment: Used for patients with metastatic NSCLC whose tumors have non-resistant EGFR mutations. Squamous NSCLC: Also indicated for the treatment of advanced squamous cell carcinoma of the lung that has progressed after platinum-based chemotherapy. Administration: * Empty Stomach Requirement: It must be taken at least 1 hour before or 2 hours after a meal. Food significantly affects the absorption of the medicine. Consistency: Tablets should be taken at approximately the same time every day with water . Clinical Side Effects & Safety Dermatological Reactions: Skin rash, acne, and dry skin are very common. Patients are advised to limit sun exposure and use protective clothing and sunscreen. Gastrointestinal Effects: Diarrhea is a frequent side effect and can become severe. Early management with anti-diarrheal medication and hydration is essential. Mouth and Nail Problems: Stomatitis (mouth sores) and paronychia (inflammation around the nails) may occur. Serious Warnings: Report any sudden breathing problems, cough, or fever immediately, as these may indicate rare but serious interstitial lung disease (ILD). Contraindication: Afatinib is contraindicated during pregnancy and breastfeeding. Reliable contraception is required during and for at least two weeks after treatment. Why Source from Ernest Oncology? United Kingdom (London): Providing high-quality, cost-effective oncology alternatives for private and public healthcare sectors. USA: Delivering bulk quantities that comply with international documentation and safety standards. Australia: Ensuring consistent access through professional pharmacy channels and the “Special Access Scheme“ (SAS). South Africa: Bridging the gap in the local market with affordable, high-tier pharmaceutical exports from India. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us
